These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28496831)

  • 1. Role of Atrio-Ventricular Junction Ablation in Symptomatic Atrial Fibrillation for Optimization of Cardiac Resynchronization Therapy.
    Garabelli PJ; Stavrakis S
    J Atr Fibrillation; 2013; 5(6):787. PubMed ID: 28496831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
    Stavrakis S; Garabelli P; Reynolds DW
    Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.
    Gasparini M; Auricchio A; Metra M; Regoli F; Fantoni C; Lamp B; Curnis A; Vogt J; Klersy C;
    Eur Heart J; 2008 Jul; 29(13):1644-52. PubMed ID: 18390869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrioventricular Junction Ablation In Atrial Fibrillation: Choosing The Right Patient And Pacing Device.
    Akerström F; Mañero MR; Pachón M; Puchol A; López XA; Sande LM; Valderrábano M; Arias MA
    J Atr Fibrillation; 2015; 8(2):1253. PubMed ID: 27957188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrioventricular junction ablation followed by resynchronization therapy in patients with congestive heart failure and atrial fibrillation (AVERT-AF) study design.
    Hamdan MH; Freedman RA; Gilbert EM; Dimarco JP; Ellenbogen KA; Page RL
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1081-8. PubMed ID: 17038140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Benefit of Atrioventricular Junction Ablation for Permanent Atrial Fibrillation and Heart Failure Patients Receiving Cardiac Resynchronization Therapy: An Updated Systematic Review and Meta-analysis.
    Waranugraha Y; Rizal A; Setiawan D; Aziz IJ
    Indian Pacing Electrophysiol J; 2021; 21(2):101-111. PubMed ID: 33548449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies.
    Mustafa U; Atkins J; Mina G; Dawson D; Vanchiere C; Duddyala N; Jones R; Reddy P; Dominic P
    Open Heart; 2019; 6(1):e000937. PubMed ID: 31217991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
    Bradley DJ; Shen WK
    Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
    Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
    Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard CRT-D device.
    Chase D; Kumar V; Hooda A
    J Saudi Heart Assoc; 2013 Jul; 25(3):213-8. PubMed ID: 24174862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response?
    Tolosana JM; Arnau AM; Madrid AH; Macias A; Lozano IF; Osca J; Quesada A; Toquero J; Francés RM; Bolao IG; Berruezo A; Sitges M; Alcalá MG; Brugada J; Mont L;
    Eur J Heart Fail; 2012 Jun; 14(6):635-41. PubMed ID: 22396459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Resynchronization Therapy and Atrial Fibrillation.
    Kamath GS; Steinberg JS
    J Atr Fibrillation; 2011; 4(3):334. PubMed ID: 28496698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrio-ventricular junction ablation and pacemaker treatment: a comparison between men and women.
    Carnlöf C; Insulander P; Jensen-Urstad M; Iwarzon M; Gadler F
    Scand Cardiovasc J; 2018 Jun; 52(3):120-126. PubMed ID: 29537317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Cardiac Resynchronization Therapy for Patients with Atrial Fibrillation: The Role of AV Node Ablation.
    M Berry J; AJoglar J
    J Atr Fibrillation; 2012; 4(6):438. PubMed ID: 28496731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis.
    Xue Y; Wang J; Wang J; Thapa S; Huang K; Peng Y; Qian L; Li J; Ji K
    Heart Fail Rev; 2019 May; 24(3):335-342. PubMed ID: 30610455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
    Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
    Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.
    Brignole M; Pokushalov E; Pentimalli F; Palmisano P; Chieffo E; Occhetta E; Quartieri F; Calò L; Ungar A; Mont L;
    Eur Heart J; 2018 Dec; 39(45):3999-4008. PubMed ID: 30165479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation.
    Himmel F; Reppel M; Mortensen K; Schunkert H; Bode F
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):943-7. PubMed ID: 22650352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.